Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of GTPBP1 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of GTPBP1 mRNA | CTD | PMID:17108234 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP1 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of GTPBP1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GTPBP1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GTPBP1 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of GTPBP1 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | increases methylation | ISO | GTPBP1 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of GTPBP1 gene | CTD | PMID:31601247 | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GTPBP1 mRNA | CTD | PMID:19038236 | 5-aza-2'-deoxycytidine | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Decitabine results in increased expression of GTPBP1 mRNA | CTD | PMID:19194470 | all-trans-retinoic acid | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GTPBP1 mRNA | CTD | PMID:33167477 | arsenite(3-) | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to GTPBP1 mRNA] | CTD | PMID:32406909 | bisphenol A | affects expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of GTPBP1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | GTPBP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of GTPBP1 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GTPBP1 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of GTPBP1 mRNA | CTD | PMID:29275510 | bisphenol F | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of GTPBP1 gene | CTD | PMID:31601247 | bortezomib | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of GTPBP1 mRNA | CTD | PMID:20977926 | cadmium atom | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTPBP1 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTPBP1 mRNA | CTD | PMID:35301059 | caffeine | affects phosphorylation | ISO | GTPBP1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of GTPBP1 protein | CTD | PMID:35688186 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of GTPBP1 mRNA | CTD | PMID:37019170 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of GTPBP1 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTPBP1 gene | CTD | PMID:20938992 | clobetasol | increases expression | EXP | | 6480464 | Clobetasol results in increased expression of GTPBP1 mRNA | CTD | PMID:27462272 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of GTPBP1 mRNA | CTD | PMID:17585979 | coumarin | decreases phosphorylation | ISO | GTPBP1 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of GTPBP1 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GTPBP1 mRNA | CTD | PMID:25562108 | cytarabine | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of GTPBP1 mRNA | CTD | PMID:19194470 | dicrotophos | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of GTPBP1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTPBP1 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GTPBP1 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GTPBP1 protein | CTD | PMID:23301498 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of GTPBP1 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of GTPBP1 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GTPBP1 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of GTPBP1 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTPBP1 gene | CTD | PMID:20938992 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of GTPBP1 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | ISO | GTPBP1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of GTPBP1 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of GTPBP1 gene | CTD | PMID:31601247 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GTPBP1 mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GTPBP1 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of GTPBP1 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTPBP1 gene | CTD | PMID:20938992 | leflunomide | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | leflunomide results in increased expression of GTPBP1 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GTPBP1 mRNA | CTD | PMID:23649840 | ozone | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of GTPBP1 mRNA | CTD | PMID:35430440 | paracetamol | increases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of GTPBP1 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of GTPBP1 mRNA | CTD | PMID:21371552 | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of GTPBP1 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GTPBP1 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GTPBP1 mRNA | CTD | PMID:20059764 | pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GTPBP1 mRNA] | CTD | PMID:20059764 | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of GTPBP1 mRNA | CTD | PMID:23608068 | SB 431542 | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTPBP1 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GTPBP1 protein | CTD | PMID:30528433 | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of GTPBP1 mRNA | CTD | PMID:17555576 | thioacetamide | increases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of GTPBP1 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of GTPBP1 mRNA | CTD | PMID:29264374 | urethane | increases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Urethane results in increased expression of GTPBP1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of GTPBP1 mRNA | CTD | PMID:17963808 | valproic acid | multiple interactions | ISO | GTPBP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTPBP1 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | GTPBP1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GTPBP1 mRNA | CTD | PMID:26272509 | vinclozolin | decreases expression | ISO | Gtpbp1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of GTPBP1 mRNA | CTD | PMID:23555832 | |